The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients
Clinical trial NCT05168527 · UNKNOWN
Trial details
- NCT number
- NCT05168527
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2024-03-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.